Cargando…

Neutralizing activity and T Cell response after bivalent fifth dose of mRNA vaccine in person living with HIV

OBJECTIVES: To investigate immunogenicity of SARS-CoV-2 vaccine third booster (3BD; fifth dose) with bivalent vaccine original/BA4/5 vaccine in people living with HIV (PLWH). STUDY DESIGN: This is an observational cohort study to evaluate the outcomes of SARS-CoV-2 vaccination (HIV-VAC study). We an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vergori, Alessandra, Matusali, Giulia, Lepri, Alessandro Cozzi, Cimini, Eleonora, Fusto, Marisa, Colavita, Francesca, Gagliardini, Roberta, Notari, Stefania, Mazzotta, Valentina, Mariotti, Davide, Cicalini, Stefania, Girardi, Enrico, Vaia, Francesco, Maggi, Fabrizio, Antinori, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277256/ https://www.ncbi.nlm.nih.gov/pubmed/37343783 http://dx.doi.org/10.1016/j.ijid.2023.06.010

Ejemplares similares

SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH
por: Vergori, Alessandra, et al.
Publicado: (2022)

Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
por: Antinori, Andrea, et al.
Publicado: (2022)

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2022)

SARS-CoV-2 Specific Immune Response and Inflammatory Profile in Advanced HIV-Infected Persons during a COVID-19 Outbreak
por: Vergori, Alessandra, et al.
Publicado: (2022)

Asymptomatic Mpox Virus Infection in Subjects Presenting for MVA-BN Vaccine
por: Matusali, Giulia, et al.
Publicado: (2023)

Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH
por: Gagliardini, Roberta, et al.
Publicado: (2022)

Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV
por: Mastrorosa, Ilaria, et al.
Publicado: (2022)

Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022
por: Pittalis, Silvia, et al.
Publicado: (2022)

Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding
por: Lapa, Daniele, et al.
Publicado: (2022)

In Vitro and In Vivo Crosstalk between Type I IFN and IL-8 Responses in SARS-CoV-2 Infection
por: Biava, Mirella, et al.
Publicado: (2023)

A Case of Severe Mpox Complicated with Streptococcus pyogenes Sepsis in a Patient with HIV Infection
por: Di Bari, Silvia, et al.
Publicado: (2023)

SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis
por: Mastrorosa, Ilaria, et al.
Publicado: (2022)

Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia
por: Vergori, Alessandra, et al.
Publicado: (2021)

SARS-CoV-2 infection does not induce HIV viral escape in the central nervous system: A case series
por: Pinnetti, C., et al.
Publicado: (2020)

Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19
por: Mazzotta, Valentina, et al.
Publicado: (2022)

Kinetics of TTV Loads in Peripheral Blood Mononuclear Cells of Early Treated Acute HIV Infections
por: Abbate, Isabella, et al.
Publicado: (2023)

Viral load decrease in SARS‐CoV‐2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents
por: Valentina, Mazzotta, et al.
Publicado: (2022)

Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infection
por: Colavita, Francesca, et al.
Publicado: (2023)

SARS-CoV-2 Infection of Airway Epithelium Triggers Pulmonary Endothelial Cell Activation and Senescence Associated with Type I IFN Production
por: Bordoni, Veronica, et al.
Publicado: (2022)

Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study
por: Agrati, Chiara, et al.
Publicado: (2023)

No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison
por: Gagliardini, Roberta, et al.
Publicado: (2021)

SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus
por: Matusali, Giulia, et al.
Publicado: (2021)

Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination
por: Matusali, Giulia, et al.
Publicado: (2023)

Monkeypox virus in human body sites and fluids: evidence for transmission
por: Colavita, Francesca, et al.
Publicado: (2023)

Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)
por: Mastrorosa, Ilaria, et al.
Publicado: (2023)

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
por: Spaziante, Martina, et al.
Publicado: (2021)

Viral replication and infectivity of monkeypox through semen – Authors' reply
por: Lapa, Daniele, et al.
Publicado: (2022)

Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results
por: Agrati, Chiara, et al.
Publicado: (2022)

Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation
por: Ciccosanti, Fabiola, et al.
Publicado: (2022)

The interplay between SARS-CoV-2 infected airway epithelium and immune cells modulates regulatory/inflammatory signals
por: Bordoni, Veronica, et al.
Publicado: (2022)

Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients
por: Peled, Yael, et al.
Publicado: (2023)

Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good
por: Grassi, Germana, et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio
por: Vergori, Alessandra, et al.
Publicado: (2023)

SIGNIFICANCE OF BIVALENCE OF ANTIBODY IN VIRAL NEUTRALIZATION
por: Rosenstein, Robert W., et al.
Publicado: (1971)

SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel
por: Santoro, Annapaola, et al.
Publicado: (2023)

Ocular involvement in monkeypox: Description of an unusual presentation during the current outbreak
por: Mazzotta, V, et al.
Publicado: (2022)

Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era
por: Madeddu, Giordano, et al.
Publicado: (2021)

Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
por: Agrati, Chiara, et al.
Publicado: (2022)

Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy
por: Colavita, Francesca, et al.
Publicado: (2022)

Biomimetic nanoplasmonic sensor for rapid evaluation of neutralizing SARS-CoV-2 monoclonal antibodies as antiviral therapy
por: Batool, Razia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f2gqen2tcq5kv6d4f4me16k9lp